Pamicell, Surge in Investor Searches... Stock Price 20,600 KRW (-4.63%)
The search frequency for Pharmicell, known as the world's first bio-pharmaceutical company to develop stem cell therapy, has surged recently.
As of 10:32 AM on the 20th, Pharmicell's stock price is 20,600 KRW, down 4.63% from the previous day, with a trading volume of 3,188,603 shares, which is about 29.11% of the 5-day average trading volume. Foreign investors are tentatively estimated to have sold a net 48,000 shares today.
On May 19th, Pharmicell became a market issue with the headline "Soars on Expectations for US Vaccine Development."
[Table] Net Trading Volume of Foreign and Institutional Investors (Unit: Shares)
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
"Buy on Black Monday"... Japan's Nomura Forecasts 590,000 for Samsung, 4 Million for SK hynix
- "Plunged During the War, Now Surging Again"... The Real Reason Behind the 6% One-Day Silver Market Rally [Weekend Money]
- "Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"
- "We're Now Earning 10 Million Won a Month"... Semiconductor Boom Drives Performance Bonuses at Major Electronic Component Firms
- Experts Are Already Watching Closely..."Target Stock Price 970,000 Won" Now Only the Uptrend Remains [Weekend Money]
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
